cigna glp-1 coverage news Obesity Drugs: drops of GLP-1 obesity drugs for its own employees: What's the future of weight-loss treatment Cigna drops coverage of GLP-1

The FDA approved the Wegovy pill on December 22, 2025

Research has shown that GLP-1s may increase your risk of gastroparesis, also known as stomach paralysis

Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D: The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity

Top 20 Companies Leading the Global Glucagon-Like Peptide-1 agonists Market Novo Nordisk Eli Lilly and Company Sanofi AstraZeneca Pfizer Inc

Adipose tissue produces and releases the hormone leptin in proportion to the amount of stored fat

If youve been searching for GLP-1 weight loss services near me in Maryland, DC, or Virginia, look no furtherour personalized approach and convenient location make us the top choice for patients across the DMV